1. Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies

   • Georgia Ragia
   • Vangelis G. Manolopoulos

   Review 21 July 2020 Pages: 1623 - 1630

   

2. Efficacy and safety of corticosteroid therapy in patients with cardiac arrest: a systematic review of randomised controlled trials

   • Yajie Li
   • Jun Zhang
   • Fei He

   Review 21 July 2020 Pages: 1631 - 1638

   

3. Efficacy and safety profile of statins in patients with cancer: a systematic review of randomised controlled trials

   • John P. Thomas
   • Yoon K. Loke
   • Leo Alexandre

   Review Open access 28 July 2020 Pages: 1639 - 1651

   

4. Cinemeducation in clinical pharmacology: using cinema to help students learn about pharmacovigilance and adverse drug reactions

   • Irene Cambra-Badii
   • María de Lluc Francés
   • Josep-E Baños

   Pharmacodynamics 04 September 2020 Pages: 1653 - 1658

5. Evaluation of drug-drug interaction of lusutrombopag, a thrombopoietin receptor agonist, via metabolic enzymes and transporters

   • Takayuki Katsube
   • Yuji Inoue
   • Toshihiro Wajima

   Pharmacokinetics and Disposition Open access 14 July 2020 Pages: 1659 - 1665

   

6. Flucloxacillin decreases tacrolimus blood trough levels: a single-center retrospective cohort study

   • Herman Veenhof
   • Hugo M. Schouw
   • Valentina Gracchi

   Pharmacokinetics and Disposition Open access 25 July 2020 Pages: 1667 - 1673

   

7. Use of the French healthcare insurance database to estimate the prevalence of exposure to potential drug-drug interactions

   • Cécile Souty
   • Titouan Launay
   • Thomas Hanslik

   Pharmacoepidemiology and Prescription 07 July 2020 Pages: 1675 - 1682

   

8. Correct use of non-indexed eGFR for drug dosing and renal drug-related problems at hospital admission

   • Sarah Seiberth
   • Dominik Bauer
   • Dorothea Strobach

   Pharmacoepidemiology and Prescription Open access 10 July 2020 Pages: 1683 - 1693

   

9. Pain severity and analgesics use in the community-dwelling older population: a drug utilization study from Germany

   • Thi Ngoc Mai Nguyen
   • Dana Clarissa Laetsch
   • Ben Schöttker

   Pharmacoepidemiology and Prescription Open access 10 July 2020 Pages: 1695 - 1707

   

10. Safety of azithromycin in pediatrics: a systematic review and meta-analysis

    • Linan Zeng
    • Peipei Xu
    • Lingli Zhang

    Pharmacoepidemiology and Prescription Open access 17 July 2020 Pages: 1709 - 1721

    

11. Patients’ experiences on adverse drug reactions reporting: a qualitative study

    • Rania Al Dweik
    • Sanni Yaya
    • Dafna Kohen

    Pharmacoepidemiology and Prescription 13 July 2020 Pages: 1723 - 1730

12. Comparative effectiveness of dopamine agonists and monoamine oxidase type-B inhibitors for Parkinson’s disease: a multiple treatment comparison meta-analysis

    • Caroline D. Binde
    • Ingunn F. Tvete
    • Marianne Klemp

    Pharmacoepidemiology and Prescription Open access 24 July 2020 Pages: 1731 - 1743

    

13. Blood pressure–lowering activity of statins: a systematic literature review and meta-analysis of placebo-randomized controlled trials

    • Jahad Alghamdi
    • Abdulziz Alqadi
    • Sandosh Padmanabhan

    Pharmacoepidemiology and Prescription 21 July 2020 Pages: 1745 - 1754

    

14. Association of in-hospital intensive statins dosage and death in arteriosclerotic cardiovascular disease with percutaneous coronary intervention: insights of multicentre cohort from China

    • Peng-yuan Chen
    • Yuan-hui Liu
    • Peng-cheng He

    Pharmacoepidemiology and Prescription 22 July 2020 Pages: 1755 - 1763

    

15. Drug exposure for PDA closure in France: a prospective, cohort-based, analysis

    • Silvia Iacobelli
    • Simon Lorrain
    • Francesco Bonsante

    Pharmacoepidemiology and Prescription 01 August 2020 Pages: 1765 - 1772

    

16. Durvalumab and multiple sclerosis: a causal link or simple unmasking?

    • Francesca Caputo
    • Alessia Manni
    • Damiano Paolicelli

    Letter to the Editor 13 July 2020 Pages: 1773 - 1774

    

17. Safety of fluoxetine use in children and adolescents: a disproportionality analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) database

    • Iole N. Christodoulos
    • Te-yuan Chyou
    • Prasad S. Nishtala

    Letter to the Editor 28 July 2020 Pages: 1775 - 1776